232 related articles for article (PubMed ID: 8938664)
1. Opioid receptor agonists activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase in canine cardiac sarcolemma.
Niroomand F; Mura RA; Piacentini L; Kübler W
Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):643-9. PubMed ID: 8938664
[TBL] [Abstract][Full Text] [Related]
2. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein.
Lawrence DM; Bidlack JM
J Pharmacol Exp Ther; 1993 Sep; 266(3):1678-83. PubMed ID: 8103800
[TBL] [Abstract][Full Text] [Related]
3. Activation of type II adenylyl cyclase by the cloned mu-opioid receptor: coupling to multiple G proteins.
Chan JS; Chiu TT; Wong YH
J Neurochem; 1995 Dec; 65(6):2682-9. PubMed ID: 7595566
[TBL] [Abstract][Full Text] [Related]
4. Go mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain.
Carter BD; Medzihradsky F
Proc Natl Acad Sci U S A; 1993 May; 90(9):4062-6. PubMed ID: 8097884
[TBL] [Abstract][Full Text] [Related]
5. Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells.
Piros ET; Prather PL; Loh HH; Law PY; Evans CJ; Hales TG
Mol Pharmacol; 1995 May; 47(5):1041-9. PubMed ID: 7746271
[TBL] [Abstract][Full Text] [Related]
6. Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gbetagamma.
Avidor-Reiss T; Nevo I; Levy R; Pfeuffer T; Vogel Z
J Biol Chem; 1996 Aug; 271(35):21309-15. PubMed ID: 8702909
[TBL] [Abstract][Full Text] [Related]
7. Mu-opioid agonist enhancement of prostaglandin-induced hyperalgesia in the rat: a G-protein beta gamma subunit-mediated effect?
Khasar SG; Wang JF; Taiwo YO; Heller PH; Green PG; Levine JD
Neuroscience; 1995 Jul; 67(1):189-95. PubMed ID: 7477899
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling.
Yabaluri N; Medzihradsky F
Mol Pharmacol; 1997 Nov; 52(5):896-902. PubMed ID: 9351981
[TBL] [Abstract][Full Text] [Related]
9. mu-Opioid receptor stimulation of inositol (1,4,5)trisphosphate formation via a pertussis toxin-sensitive G protein.
Smart D; Smith G; Lambert DG
J Neurochem; 1994 Mar; 62(3):1009-14. PubMed ID: 8113787
[TBL] [Abstract][Full Text] [Related]
10. Modulation of adenylate cyclase activity of mouse spinal cord-ganglion explants by opioids, serotonin and pertussis toxin.
Makman MH; Dvorkin B; Crain SM
Brain Res; 1988 Apr; 445(2):303-13. PubMed ID: 3370465
[TBL] [Abstract][Full Text] [Related]
11. Reversible modulation of opioid receptor binding in intact neural cells by endogenous guanosine triphosphate.
Yabaluri N; Medzihradsky F
Mol Pharmacol; 1995 Oct; 48(4):690-5. PubMed ID: 7476895
[TBL] [Abstract][Full Text] [Related]
12. kappa-Opioid receptor activates an inwardly rectifying K+ channel by a G protein-linked mechanism: coexpression in Xenopus oocytes.
Ma GH; Miller RJ; Kuznetsov A; Philipson LH
Mol Pharmacol; 1995 May; 47(5):1035-40. PubMed ID: 7746270
[TBL] [Abstract][Full Text] [Related]
13. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells.
Clark MJ; Traynor JR
J Pharmacol Exp Ther; 2005 Feb; 312(2):809-15. PubMed ID: 15383633
[TBL] [Abstract][Full Text] [Related]
14. Opioid-inhibited adenylyl cyclase in rat brain membranes: lack of correlation with high-affinity opioid receptor binding sites.
Nijssen PC; Sexton T; Childers SR
J Neurochem; 1992 Dec; 59(6):2251-62. PubMed ID: 1331327
[TBL] [Abstract][Full Text] [Related]
15. Constitutively active mu-opioid receptors inhibit adenylyl cyclase activity in intact cells and activate G-proteins differently than the agonist [D-Ala2,N-MePhe4,Gly-ol5]enkephalin.
Liu JG; Ruckle MB; Prather PL
J Biol Chem; 2001 Oct; 276(41):37779-86. PubMed ID: 11500514
[TBL] [Abstract][Full Text] [Related]
16. Mu type opioid receptors in rat periaqueductal gray-enriched P2 membrane are coupled to G-protein-mediated inhibition of adenylyl cyclase.
Fedynyshyn JP; Lee NM
FEBS Lett; 1989 Aug; 253(1-2):23-7. PubMed ID: 2547657
[TBL] [Abstract][Full Text] [Related]
17. Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells.
Roerig SC; Loh HH; Law PY
Mol Pharmacol; 1992 May; 41(5):822-31. PubMed ID: 1317000
[TBL] [Abstract][Full Text] [Related]
18. Altered adenylyl cyclase responsiveness subsequent to point mutations of Asp 128 in the third transmembrane domain of the delta-opioid receptor.
Cavalli A; Babey AM; Loh HH
Neuroscience; 1999; 93(3):1025-31. PubMed ID: 10473267
[TBL] [Abstract][Full Text] [Related]
19. 3H-naloxone benzoylhydrazone binding in MOR-1-transfected Chinese hamster ovary cells: evidence for G-protein-dependent antagonist binding.
Brown GP; Pasternak GW
J Pharmacol Exp Ther; 1998 Jul; 286(1):376-81. PubMed ID: 9655882
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
Puttfarcken PS; Werling LL; Cox BM
Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
